Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention

Journal of Cellular and Molecular Medicine
K Iqbal, I Grundke-Iqbal

Abstract

Alzheimer disease (AD) is multi-factorial and heterogeneous. Independent of the aetiology, this disease is characterized clinically by chronic and progressive dementia and histopathologically by neurofibrillary degeneration of abnormally hyperphosphorylated tau seen as intraneuronal neurofibrillary tangles, neuropil threads and dystrophic neurites, and by neuritic (senile) plaques of beta-amyloid. The neurofibrillary degeneration is apparently required for the clinical expression of AD, and in related tauopathies it leads to dementia in the absence of amyloid plaques. While normal tau promotes assembly and stabilizes microtubules, the abnormally hyperphosphorylated tau sequesters normal tau, MAP1 and MAP2, and disrupts microtubules. The abnormal hyperphosphorylation of tau also promotes its self-assembly into tangles of paired helical and or straight filaments. Tau is phosphorylated by a number of protein kinases. Glycogen synthase kinase-3 (GSK-3) and cyclin dependent protein kinase 5 (cdk5) are among the kinases most implicated in the abnormal hyperphosphorylation of tau. Among the phosphatases which regulate the phosphorylation of tau, protein phosphatase-2A (PP-2A), the activity of which is down-regulated in AD brain, is by...Continue Reading

References

May 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·M D WeingartenM W Kirschner
Apr 10, 1992·Science·J A Hardy, G A Higgins
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M NovakC M Wischik
Dec 6, 1991·Brain Research·G P WangI Grundke-Iqbal
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K IqbalT Zaidi
Jan 1, 1989·Annual Review of Biochemistry·P Cohen
Jan 1, 1988·Methods in Enzymology·P CohenH Y Tung
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G PerryV Chau
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Dec 15, 1986·Biochemical and Biophysical Research Communications·E Montejo de GarciniJ Avila
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Sep 6, 1974·Brain Research·K IqbalR D Terry
Sep 1, 1970·Journal of the Neurological Sciences·B E TomlinsonM Roth
Jan 13, 1995·The Journal of Biological Chemistry·M Morishima-KawashimaY Ihara
Mar 3, 1995·The Journal of Biological Chemistry·J Z WangK Iqbal
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·A C AlonsoK Iqbal
Sep 1, 1993·Journal of Neurochemistry·C X GongK Iqbal
Feb 15, 1993·Archives of Biochemistry and Biophysics·D L MillerK Iqbal

❮ Previous
Next ❯

Citations

Feb 22, 2011·Acta neurochirurgica·Madoka NakajimaYasuhiro Hashimoto
Feb 20, 2009·Cellular and Molecular Neurobiology·Branislav KovacechMichal Novak
Mar 29, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Robert A WhittingtonEmmanuel Planel
Apr 17, 2010·Cell Death and Differentiation·P CalissanoN Canu
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eva-Maria Mandelkow, Eckhard Mandelkow
Nov 10, 2012·Therapeutic Advances in Neurological Disorders·Mirko BiblJens Wiltfang
Apr 26, 2011·Chinese Medicine·Yuen-Shan HoRaymond Chuen-Chung Chang
Sep 15, 2009·Biological Chemistry·Zhu Li, Jeffry B Stock
Sep 11, 2009·Indian Journal of Psychiatry·E MohandasB Raghunath
Oct 21, 2009·ASN Neuro·Jürgen Götz, Naeman N Götz
Jan 10, 2013·Annual Review of Clinical Psychology·Shannon L Risacher, Andrew J Saykin
Oct 27, 2011·Journal of Aging Research·J ThomeF Häßler
Nov 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Hong-Bin LuoJian-Zhi Wang
Dec 1, 2009·Biochimica Et Biophysica Acta·Dina MorshediMohsen Nemat-Gorgani
Jul 9, 2014·Journal of Neuropathology and Experimental Neurology·Carol A ColtonMichael P Vitek
Aug 19, 2015·Brain : a Journal of Neurology·Heiko Braak, Kelly Del Tredici
Jun 13, 2012·International Journal of Alzheimer's Disease·Michala KolarovaDaniela Ripova
Apr 12, 2016·Frontiers in Pharmacology·Lieven D DeclercqGuy Bormans
Apr 23, 2015·Virchows Archiv : an International Journal of Pathology·Neena Theresa KumarJan Mæhlen
Jun 5, 2015·Frontiers in Aging Neuroscience·Javier G Villamil-Ortiz, Gloria P Cardona-Gomez
Jan 26, 2010·Neurobiology of Aging·José Luis Vázquez-HigueraOnofre Combarros
Dec 6, 2011·Progress in Neurobiology·Antero SalminenIrina Alafuzoff
Mar 17, 2017·The Journal of Nutritional Biochemistry·Syed H OmarHassan K Obied
Dec 20, 2017·Journal of Alzheimer's Disease : JAD·Jaume FolchAntoni Camins
Jun 24, 2016·American Journal of Physiology. Cell Physiology·Frauke Liebelt, Alfred C O Vertegaal
Dec 2, 2008·Journal of Cellular and Molecular Medicine·Yif'at BiranPaul A Adlard

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
glycosylation

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.